177 related articles for article (PubMed ID: 34324153)
1. The Synergistic Anticancer Traits of Graphene Oxide Plus Doxorubicin Against BT474 and MCF7 Breast Cancer Stem Cells In Vitro.
Ebrahimi M; Teimouri M; Pooladi M
Appl Biochem Biotechnol; 2021 Nov; 193(11):3586-3601. PubMed ID: 34324153
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
[TBL] [Abstract][Full Text] [Related]
3. The Characters of Graphene Oxide Nanoparticles and Doxorubicin Against HCT-116 Colorectal Cancer Cells In Vitro.
Banoon SR; Ghasemian A
J Gastrointest Cancer; 2022 Jun; 53(2):410-414. PubMed ID: 33742370
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line.
Ramazi S; Salimian M; Allahverdi A; Kianamiri S; Abdolmaleki P
Sci Rep; 2023 May; 13(1):8844. PubMed ID: 37258563
[TBL] [Abstract][Full Text] [Related]
5. Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect.
Han C; Zhang C; Ma T; Zhang C; Luo J; Xu X; Zhao H; Chen Y; Kong L
Acta Biomater; 2018 Sep; 77():268-281. PubMed ID: 30006311
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effect of GO-PEG-DOX Complex on EMT-6 Mouse Breast Cancer Cells.
Yan J; Song B; Hu W; Meng Y; Niu F; Han X; Ge Y; Li N
Cancer Biother Radiopharm; 2018 May; 33(4):125-130. PubMed ID: 29763376
[TBL] [Abstract][Full Text] [Related]
7. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.
Fouad MA; Sayed-Ahmed MM; Huwait EA; Hafez HF; Osman AM
BMC Pharmacol Toxicol; 2021 Jan; 22(1):8. PubMed ID: 33509300
[TBL] [Abstract][Full Text] [Related]
9. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
[TBL] [Abstract][Full Text] [Related]
10. Cell viability and electrical response of breast cancer cell treated in aqueous graphene oxide solution deposition on interdigitated electrode.
Ramli MM; Rosman AS; Mazlan NS; Ahmad MF; Halin DSC; Mohamed R; Osman NH; Reshak AH
Sci Rep; 2021 Oct; 11(1):20702. PubMed ID: 34667216
[TBL] [Abstract][Full Text] [Related]
11. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
12. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded magnetism nanoparticles based on cyclodextrin dendritic-graphene oxide inhibited MCF-7 cell proliferation.
Mihanfar A; Targhazeh N; Sadighparvar S; Darband SG; Majidinia M; Yousefi B
Biomol Concepts; 2021 Apr; 12(1):8-15. PubMed ID: 33878249
[TBL] [Abstract][Full Text] [Related]
14. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.
Wu S; Zhao X; Cui Z; Zhao C; Wang Y; Du L; Li Y
Int J Nanomedicine; 2014; 9():1413-21. PubMed ID: 24672235
[TBL] [Abstract][Full Text] [Related]
16. POxylated graphene oxide nanomaterials for combination chemo-phototherapy of breast cancer cells.
de Melo-Diogo D; Costa EC; Alves CG; Lima-Sousa R; Ferreira P; Louro RO; Correia IJ
Eur J Pharm Biopharm; 2018 Oct; 131():162-169. PubMed ID: 30134185
[TBL] [Abstract][Full Text] [Related]
17. Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.
Jabłońska-Trypuć A; Świderski G; Krętowski R; Lewandowski W
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677642
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of cisplatin and doxorubicin by carboxylic acid functionalized poly (hydroxyethyl methacrylate)/reduced graphene nanocomposite for combination chemotherapy of breast cancer cells.
Astani S; Salehi R; Massoumi B; Massoudi A
J Biomater Sci Polym Ed; 2021 Apr; 32(5):657-677. PubMed ID: 33347395
[TBL] [Abstract][Full Text] [Related]
19. Selenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon Cancers.
Abd-Rabou AA; Ahmed HH; Shalby AB
Biol Trace Elem Res; 2020 Feb; 193(2):377-389. PubMed ID: 31066020
[TBL] [Abstract][Full Text] [Related]
20. Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.
Mohammed S; Shamseddine AA; Newcomb B; Chavez RS; Panzner TD; Lee AH; Canals D; Okeoma CM; Clarke CJ; Hannun YA
Breast Cancer Res; 2021 Jul; 23(1):76. PubMed ID: 34315513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
